Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer
Ontology highlight
ABSTRACT: Phase II trial to study the effectiveness of imatinib mesylate in treating patients who have stage IV colorectal cancer. Imatinib mesylate may interfere with the growth of tumor cells by blocking certain enzymes necessary for cancer cell growth
DISEASE(S): Stage Iv Colon Cancer,Recurrent Colon Cancer,Rectal Neoplasms,Stage Iv Rectal Cancer,Recurrent Rectal Cancer,Colonic Neoplasms
PROVIDER: 2007915 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA